Federal regulators' murky response to the rapid legalization of the hemp extract CBD has created a patchwork of state responses - ranging from broadly permissive to raids on retailers and seizures of trailers loaded with lucrative leaf. At a meeting Friday, FDA panelists asked pharmaceutical companies and patient organizations whether the widespread availability of off-the-shelf CBD products - ranging from pet food to skin oils touted as salves for all sorts of ailments - had an impact on effort...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
